| Washington H. Soul Pattinson and Co. Limited (SOL) ORDINARY FULLY PAID |
Financials |
$14,441 |
Change in substantial holding for LAU
|
27 Feb 2025 4:26PM |
$34.700 |
$38.010 |
risen by
9.54%
|
|
| Lindsay Australia Limited (LAU) ORDINARY FULLY PAID |
Industrials |
$257 |
Change in substantial holding from SOL
|
27 Feb 2025 4:26PM |
$0.635 |
$0.705 |
risen by
11.02%
|
|
| Firstwave Cloud Technology Limited (FCT) ORDINARY FULLY PAID |
Information Technology |
$11 |
Half Year Report and Accounts
|
27 Feb 2025 4:25PM |
$0.022 |
$0.005 |
fallen by
77.27%
|
|
FCT - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue declined by 21.8% to $4,521,849.
- Gross profit decreased by 18.0% to $3,839,414.
- Loss after income tax improved by 13.3% to $2,051,505.
- Main reasons for revenue decline included Telstra discontinuing its GPA firewall product.
- The company launched new network management technology called 'opHA Message Bus'.
- Recurring revenue represented 96.5% of total revenue.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Opyl Limited (OPL) ORDINARY FULLY PAID |
Information Technology |
- |
OPL - Appendix 4D & Half Year Results
|
27 Feb 2025 4:24PM |
$0.021 |
$0.022 |
risen by
4.76%
|
|
OPL - Price-sensitive ASX Announcement
Full Release
Key Points
- Opyl Limited reported a loss of $683,192 for the half-year ending 31 December 2024.
- Revenue decreased by 82.7% to $42,146 compared to the previous year.
- The company has not declared or paid any dividends during the reporting period.
- A joint venture with X Firm Ltd was established to expand TrialKey into new markets.
- Opyl's cash position was $329,547, with additional funding from loans.
- TrialKey achieved 92% predictive accuracy for clinical trial outcomes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BPH Energy Ltd (BPH) ORDINARY FULLY PAID |
Financials |
$14 |
Half Yearly Report and Accounts
|
27 Feb 2025 4:23PM |
$0.010 |
$0.010 |
fallen by
0%
|
|
BPH - Price-sensitive ASX Announcement
Full Release
Key Points
- BPH reported a profit of $7,068,242 for the half-year ending 31 December 2024.
- Revenues increased by 94.7% to $390,921.
- The company experienced a fair value gain of $7,730,474 from investments.
- Net assets rose by 31.5%, totaling $38,531,092.
- No dividends were proposed for the current or prior period.
- Material uncertainty exists around the carrying value of loans to Advent Energy Limited.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PYC Therapeutics Limited (PYC) ORDINARY FULLY PAID |
Health Care |
$1,403 |
Ceasing to be a substantial holder
|
27 Feb 2025 4:22PM |
$1.255 |
$1.490 |
risen by
18.73%
|
|
| NTAW Holdings Limited (NTD) ORDINARY FULLY PAID |
Consumer Discretionary |
$41 |
Half-Year Results Presentation
|
27 Feb 2025 4:22PM |
$0.185 |
$0.245 |
risen by
32.43%
|
|
NTD - Price-sensitive ASX Announcement
Full Release
Key Points
- NTAW Holdings reported a net loss of $42.84 million in 1H25.
- Revenue for 1H25 was $262.5 million, down from $264.3 million in 1H24.
- Gross profit margin declined to 28.9% from 31.2% year-over-year.
- The decline in profitability was attributed to lower sales volume and price discounting.
- The company has implemented a recovery plan focusing on cost reductions and debt management.
- No dividend will be declared for 1H25 due to poor trading performance.
- NTAW Holdings is transitioning away from the Dunlop brand, which did not meet sales expectations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Brainchip Holdings Ltd (BRN) ORDINARY FULLY PAID |
Information Technology |
$304 |
Annual Report
|
27 Feb 2025 4:22PM |
$0.258 |
$0.135 |
fallen by
47.57%
|
|
| NTAW Holdings Limited (NTD) ORDINARY FULLY PAID |
Consumer Discretionary |
$41 |
Half-Year Results Announcement
|
27 Feb 2025 4:22PM |
$0.185 |
$0.245 |
risen by
32.43%
|
|
NTD - Price-sensitive ASX Announcement
Full Release
Key Points
- NTAW reported a net loss of $42.8 million for 1H25.
- The loss includes a non-cash impairment charge of $39.2 million.
- Revenue decreased to $262.5 million from $264.3 million in 1H24.
- Gross profit margin fell to 28.9% from 31.2% in 1H24.
- Operating costs rose to 25.7% of revenue compared to 24.1% in 1H24.
- Net operating cash flow was negative $9.7 million.
- The company's net debt position increased to $64.2 million.
- Cost-cutting initiatives are being implemented to improve financial performance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Metal Powder Works Limited (MPW) ORDINARY FULLY PAID |
Industrials |
$278 |
Half Year Report to 31 December 2024
|
27 Feb 2025 4:21PM |
$0.075 |
$2.520 |
risen by
3,260%
|
|
MPW - Price-sensitive ASX Announcement
Full Release
Key Points
- Loss after income tax reduced to $488,575 from $2,006,202.
- Revenue decreased slightly from $1,476,906 to $1,378,796.
- The company announced a binding agreement to acquire Metal Powder Works Inc.
- The name change to Metal Powder Works Limited was effective February 18, 2025.
- Net cash used in operating activities was $419,443.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$302 |
Appendix 3Y - Change of Director's Interest Notice x6
|
27 Feb 2025 4:19PM |
$1.150 |
$0.955 |
fallen by
16.96%
|
|
| NTAW Holdings Limited (NTD) ORDINARY FULLY PAID |
Consumer Discretionary |
$41 |
Appendix 4D & Half Year Financial Report
|
27 Feb 2025 4:19PM |
$0.185 |
$0.245 |
risen by
32.43%
|
|
NTD - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue for 1H25 was $262.47 million, a decrease of 0.7% from 1H24.
- NTAW reported a loss of $42.68 million compared to a profit of $0.89 million in the prior period.
- A non-cash impairment charge of $39.17 million was recorded against intangible assets.
- Net assets stood at $86.26 million, down from $117.30 million in June 2024.
- The company will cease distribution of Dunlop products effective July 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cadence Capital Limited (CDM) ORDINARY FULLY PAID |
Financials |
$240 |
Appendix 4D Half Year Report 31 December 2024
|
27 Feb 2025 4:19PM |
$0.690 |
$0.805 |
risen by
16.67%
|
|
CDM - Price-sensitive ASX Announcement
Full Release
Key Points
- Operating loss before tax of $11,840,427 for the half-year ended 31 December 2024.
- Operating profit before tax for the previous year was $10,829,240.
- Gross performance of -3.6% compared to a 6.9% increase in the All Ordinaries Accumulation Index.
- Net investments valued at $186,308,227 as of December 2024.
- Net asset value of $288,228,284 as of December 2024.
- Interim dividend of 3.0 cents per share declared, partially franked at 50%, payable on 30 April 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PYC Therapeutics Limited (PYC) ORDINARY FULLY PAID |
Health Care |
$1,403 |
Half Yearly Report and Accounts
|
27 Feb 2025 4:16PM |
$1.255 |
$1.490 |
risen by
18.73%
|
|
PYC - Price-sensitive ASX Announcement
Full Release
Key Points
- PYC Therapeutics Limited is focused on precision medicines for genetic diseases.
- The company has four first-in-class drug candidates in development.
- Positive data from phase 1/2 studies for VP-001 for Retinitis Pigmentosa Type 11.
- Dosing has commenced for PYC-001 addressing Autosomal Dominant Optic Atrophy.
- Pre-clinical studies for PYC-003 targeting Polycystic Kidney Disease have been completed.
- A clinical candidate has been nominated for Phelan-McDermid Syndrome.
- The company reported a loss of $25.87 million for the half-year ending 31 December 2024.
- PYC aims to raise capital to support development through to 2027.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| NTAW Holdings Limited (NTD) ORDINARY FULLY PAID |
Consumer Discretionary |
$41 |
Bank Facilities & Financial Covenants
|
27 Feb 2025 4:16PM |
$0.185 |
$0.245 |
risen by
32.43%
|
|
NTD - Price-sensitive ASX Announcement
Full Release
Key Points
- NTD entered into an amendment deed regarding finance facilities with the Commonwealth Bank of Australia.
- The Bank waived the Group's non-compliance with financial covenants.
- New financial covenant thresholds have been agreed upon.
- The trade finance facility limit was reduced from $93 million to $85.4 million.
- Further reduction of $12.4 million in the trade finance facility is scheduled by July 2025.
- These adjustments return the facility limit to levels prior to the Dunlop Distribution Agreements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Benjamin Hornigold Limited (BHD) ORDINARY FULLY PAID |
Financials |
$5 |
Appendix 4D and Interim Report Dec 2024
|
27 Feb 2025 4:15PM |
$0.185 |
$0.190 |
risen by
2.70%
|
|
BHD - Price-sensitive ASX Announcement
Full Release
Key Points
- Loss for the half-year increased to $464,805 from $321,616.
- Total revenue decreased due to realised and unrealised investment losses.
- Basic and diluted loss per share were both $1.92.
- Net tangible assets per ordinary security reduced to 26 cents.
- No dividends were paid, recommended, or declared during the period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ASF Group Limited (AFA) ORDINARY FULLY PAID |
Financials |
$49 |
Half Yearly Report and Accounts
|
27 Feb 2025 4:13PM |
$0.005 |
$0.062 |
risen by
1,140%
|
|
AFA - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue decreased by 5% to $404,317.
- Consolidated loss after tax was $3,333,423.
- Losses were primarily due to shares of associates and investment impairments.
- Finance costs increased to $1,408,007.
- The Group has a cash balance of $1,670,913.
- Current liabilities exceed current assets by $5,953,948.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Investigator Silver Limited (IVR) ORDINARY FULLY PAID |
Materials |
$218 |
Appendix 5B - Amended
|
27 Feb 2025 4:11PM |
$0.023 |
$0.110 |
risen by
378.26%
|
|
| Echo IQ Limited (EIQ) ORDINARY FULLY PAID |
Information Technology |
$379 |
Half Year Accounts 31 December 2024
|
27 Feb 2025 4:11PM |
$0.285 |
$0.580 |
risen by
103.51%
|
|
| Pureprofile Ltd (PPL) ORDINARY FULLY PAID |
Information Technology |
$50 |
Application for quotation of securities - PPL
|
27 Feb 2025 4:10PM |
$0.043 |
$0.043 |
fallen by
0%
|
|
| Traffic Technologies Ltd (TTI) ORDINARY FULLY PAID |
Industrials |
- |
Investor Presentation
|
27 Feb 2025 4:10PM |
$0.004 |
$0.003 |
fallen by
25%
|
|
TTI - Price-sensitive ASX Announcement
Full Release
Key Points
- Strong order book with ongoing customer contracts
- Completed relocation of production and administration facilities
- Secured contracts for smart streetlights and tunnel lighting
- Achieved significant annualized cost savings in FY24 and FY25
- Positive outlook despite reduced operating revenue
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Brainchip Holdings Ltd (BRN) ORDINARY FULLY PAID |
Information Technology |
$304 |
Appendix 4E
|
27 Feb 2025 4:08PM |
$0.258 |
$0.135 |
fallen by
47.57%
|
|
BRN - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from continuing operations increased by 72% to $398,011.
- Operating loss decreased to $24,003,713 from $28,737,748.
- Loss for the period attributable to members improved by 15% to $24,431,185.
- No dividends declared for the year ended 31 December 2024.
- Net tangible assets per share increased to $0.96 from $0.83 in 2023.
- The financial report was audited by HLB Mann Judd with an unqualified opinion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Entertainment Rewards Ltd (EAT) ORDINARY FULLY PAID |
Communication Services |
$27 |
Half Yearly Report and Accounts
|
27 Feb 2025 4:07PM |
$0.003 |
$0.021 |
risen by
600%
|
|
EAT - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 13% to $9.8 million.
- Net loss after tax was $5.66 million, up from $3.24 million the previous year.
- Operating EBITDA loss of $3.62 million compared to a loss of $1.77 million in the prior year.
- Membership sales increased by 13% on a cash basis, but decreased by 6% in the P&L due to timing differences.
- Seamless Rewards business showed strong growth with a 172% increase in success fees.
- Gift card sales rose by 27.6% with new offerings introduced.
- The company is focusing on revenue growth strategies and improving membership offerings.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Camplify Holdings Limited (CHL) ORDINARY FULLY PAID |
Industrials |
$28 |
Camplify announces changes to its Chief Financial Officer
|
27 Feb 2025 4:07PM |
$0.570 |
$0.335 |
fallen by
41.23%
|
|
| Nutritional Growth Solutions Ltd (NGS) ORDINARY FULLY PAID |
Consumer Staple |
$7 |
Preliminary Final Report
|
27 Feb 2025 4:07PM |
$0.030 |
$0.020 |
fallen by
33.33%
|
|
NGS - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue decreased by 17% from the previous year.
- Reported loss of USD 2,544,000 for the year.
- No dividends proposed or declared.
- Successful capital raise of AUD 1.525 million via share placement.
- Closing cash balance at year-end was USD 31,000.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
